Quantum Genomics Société Anonyme Balance Sheet Health
Financial Health criteria checks 3/6
Quantum Genomics Société Anonyme has a total shareholder equity of €436.7K and total debt of €2.7M, which brings its debt-to-equity ratio to 622.2%. Its total assets and total liabilities are €3.7M and €3.3M respectively.
Key information
622.2%
Debt to equity ratio
€2.72m
Debt
Interest coverage ratio | n/a |
Cash | €3.55m |
Equity | €436.66k |
Total liabilities | €3.31m |
Total assets | €3.75m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: QNNT.F's short term assets (€3.7M) exceed its short term liabilities (€1.3M).
Long Term Liabilities: QNNT.F's short term assets (€3.7M) exceed its long term liabilities (€2.0M).
Debt to Equity History and Analysis
Debt Level: QNNT.F has more cash than its total debt.
Reducing Debt: QNNT.F's debt to equity ratio has increased from 0.02% to 622.2% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if QNNT.F has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if QNNT.F has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.